A citation-based method for searching scientific literature

Tina Levstek, Eva Kozjek, Vita Dolžan, Katarina Trebušak Podkrajšek. Front Cell Neurosci 2020
Times Cited: 3







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomere length in Parkinson's disease: A meta-analysis.
Diego A Forero, Yeimy González-Giraldo, Catalina López-Quintero, Luis J Castro-Vega, George E Barreto, George Perry. Exp Gerontol 2016
31
66

Telomere length and telomerase activity in osteoporosis and osteoarthritis.
Persefoni Fragkiadaki, Dragana Nikitovic, Katerina Kalliantasi, Evangelia Sarandi, Maria Thanasoula, Polychronis D Stivaktakis, Charitini Nepka, Demetrios A Spandidos, Theodoros Tosounidis, Aristidis Tsatsakis. Exp Ther Med 2020
8
66

Telomere length measurement by qPCR - Summary of critical factors and recommendations for assay design.
Jue Lin, Dana L Smith, Kyle Esteves, Stacy Drury. Psychoneuroendocrinology 2019
41
66

Meta-analysis of Telomere Length in Alzheimer's Disease.
Diego A Forero, Yeimy González-Giraldo, Catalina López-Quintero, Luis J Castro-Vega, George E Barreto, George Perry. J Gerontol A Biol Sci Med Sci 2016
104
66

Telomere Length as Cardiovascular Aging Biomarker: JACC Review Topic of the Week.
Tim De Meyer, Tim Nawrot, Sofie Bekaert, Marc L De Buyzere, Ernst R Rietzschel, Vicente Andrés. J Am Coll Cardiol 2018
41
66

Telomere length and cardiovascular disease risk.
Yiqiang Zhan, Sara Hägg. Curr Opin Cardiol 2019
19
66

Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
Sara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan. J Neuroinflammation 2019
12
33

Research in motion: the enigma of Parkinson's disease pathology spread.
Patrik Brundin, Jia-Yi Li, Janice L Holton, Olle Lindvall, Tamas Revesz. Nat Rev Neurosci 2008
225
33

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.
Jennifer G Goldman, Beth A Vernaleo, Richard Camicioli, Nabila Dahodwala, Roseanne D Dobkin, Terry Ellis, James E Galvin, Connie Marras, Jerri Edwards, Julie Fields,[...]. NPJ Parkinsons Dis 2018
52
33

Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study.
G Zhai, A Aviv, D J Hunter, D J Hart, J P Gardner, M Kimura, X Lu, A M Valdes, T D Spector. Ann Rheum Dis 2006
51
33

Oxidative stress shortens telomeres.
Thomas von Zglinicki. Trends Biochem Sci 2002
33

Progression of Cognitive Decline in Parkinson's Disease.
Mandy Roheger, Elke Kalbe, Inga Liepelt-Scarfone. J Parkinsons Dis 2018
22
33

Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.
A D Andersen, M Binzer, E Stenager, J B Gramsbergen. Acta Neurol Scand 2017
60
33


Neurodegeneration and inflammation in Parkinson's disease.
Sudarshan Phani, John D Loike, Serge Przedborski. Parkinsonism Relat Disord 2012
144
33


Protein aggregation and neurodegenerative disease.
Christopher A Ross, Michelle A Poirier. Nat Med 2004
33

Association of NQO1 and TNF polymorphisms with Parkinson's disease: A meta-analysis of 15 genetic association studies.
Dongjun Dai, Peipei Lin, Yunliang Wang, Xingyu Zhou, Jianmin Tao, Danjie Jiang, Hanlin Zhou, Ping Ru, Guanghui Pan, Jinfeng Li,[...]. Biomed Rep 2014
7
33

NADPH Oxidase Overactivity Underlies Telomere Shortening in Human Atherosclerosis.
Álvaro Pejenaute, Adriana Cortés, Javier Marqués, Laura Montero, Óscar Beloqui, Ana Fortuño, Amelia Martí, Josune Orbe, Guillermo Zalba. Int J Mol Sci 2020
4
33

Neuromelanin of the human substantia nigra: an update.
Fabio A Zucca, Emy Basso, Francesca A Cupaioli, Emanuele Ferrari, David Sulzer, Luigi Casella, Luigi Zecca. Neurotox Res 2014
113
33


Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
Carine Coneglian de Farias, Michael Maes, Kamila Landucci Bonifácio, Chiara Cristina Bortolasci, André de Souza Nogueira, Francis Fregonesi Brinholi, Andressa Keiko Matsumoto, Matheus Amarante do Nascimento, Lúcio Baena de Melo, Suzana Lucy Nixdorf,[...]. Neurosci Lett 2016
43
33

Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity.
Wanli W Smith, Haibing Jiang, Zhong Pei, Yuji Tanaka, Hokuto Morita, Akira Sawa, Valina L Dawson, Ted M Dawson, Christopher A Ross. Hum Mol Genet 2005
269
33

Parkinson's disease: clinical features and diagnosis.
J Jankovic. J Neurol Neurosurg Psychiatry 2008
33

The molecular structure of centromeres and telomeres.
E H Blackburn. Annu Rev Biochem 1984
557
33

Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study.
Aoife O'Donovan, Matthew S Pantell, Eli Puterman, Firdaus S Dhabhar, Elizabeth H Blackburn, Kristine Yaffe, Richard M Cawthon, Patricia L Opresko, Wen-Chi Hsueh, Suzanne Satterfield,[...]. PLoS One 2011
203
33



Reduced telomere length in neurodegenerative disorders may suggest shared biology.
Lakshmi Narayanan Kota, Srikala Bharath, Meera Purushottam, Nagaraj S Moily, Palanimuthu Thangaraju Sivakumar, Mathew Varghese, Pramod Kumar Pal, Sanjeev Jain. J Neuropsychiatry Clin Neurosci 2015
28
33

Long leukocyte telomere length at diagnosis is a risk factor for dementia progression in idiopathic parkinsonism.
Sofie Degerman, Magdalena Domellöf, Mattias Landfors, Jan Linder, Mathias Lundin, Susann Haraldsson, Eva Elgh, Göran Roos, Lars Forsgren. PLoS One 2014
16
33

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.
Kelvin C Luk, Victoria Kehm, Jenna Carroll, Bin Zhang, Patrick O'Brien, John Q Trojanowski, Virginia M-Y Lee. Science 2012
33

Short telomere length is associated with impaired cognitive performance in European ancestry cohorts.
S Hägg, Y Zhan, R Karlsson, L Gerritsen, A Ploner, S J van der Lee, L Broer, J Deelen, R E Marioni, A Wong,[...]. Transl Psychiatry 2017
33
33

Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
C Warren Olanow, Karl Kieburtz, Olivier Rascol, Werner Poewe, Anthony H Schapira, Murat Emre, Helena Nissinen, Mika Leinonen, Fabrizio Stocchi. Mov Disord 2013
226
33

Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.
M San Luciano, L Ozelius, R B Lipton, D Raymond, S B Bressman, R Saunders-Pullman. Neurosci Lett 2012
12
33

The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
Nicola Biagio Mercuri, Giorgio Bernardi. Trends Pharmacol Sci 2005
139
33

Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.
Jose A Santiago, Clemens R Scherzer, Judith A Potashkin. PLoS One 2014
20
33

Association of Glycemic Control and Cell Stress With Telomere Attrition in Type 1 Diabetes.
Tine Tesovnik, Jernej Kovac, Tinka Hovnik, Klemen Dovc, Nataša Bratina, Tadej Battelino, Katarina Trebušak Podkrajšek. JAMA Pediatr 2018
12
33


Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
33


Parkinson's disease.
Lorraine V Kalia, Anthony E Lang. Lancet 2015
33

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study.
Carmen Martin-Ruiz, Caroline H Williams-Gray, Alison J Yarnall, John J Boucher, Rachael A Lawson, Ruwani S Wijeyekoon, Roger A Barker, Claire Kolenda, Craig Parker, David J Burn,[...]. J Parkinsons Dis 2020
12
33

The role of inflammation in sporadic and familial Parkinson's disease.
Michela Deleidi, Thomas Gasser. Cell Mol Life Sci 2013
104
33

Gene-environment interactions linking air pollution and inflammation in Parkinson's disease.
Pei-Chen Lee, Ole Raaschou-Nielsen, Christina M Lill, Lars Bertram, Janet S Sinsheimer, Johnni Hansen, Beate Ritz. Environ Res 2016
26
33

Pharmacological treatment of Parkinson disease: a review.
Barbara S Connolly, Anthony E Lang. JAMA 2014
621
33

Telomere extension occurs at most chromosome ends and is uncoupled from fill-in in human cancer cells.
Yong Zhao, Agnel J Sfeir, Ying Zou, Christen M Buseman, Tracy T Chow, Jerry W Shay, Woodring E Wright. Cell 2009
151
33

Time dependent ROC curves for the estimation of true prognostic capacity of microarray data.
Yohann Foucher, Richard Danger. Stat Appl Genet Mol Biol 2012
16
33

Parkinson disease.
Werner Poewe, Klaus Seppi, Caroline M Tanner, Glenda M Halliday, Patrik Brundin, Jens Volkmann, Anette-Eleonore Schrag, Anthony E Lang. Nat Rev Dis Primers 2017
33

Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
171
33

The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.
Claudio Franceschi, Paolo Garagnani, Cristina Morsiani, Maria Conte, Aurelia Santoro, Andrea Grignolio, Daniela Monti, Miriam Capri, Stefano Salvioli. Front Med (Lausanne) 2018
198
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.